Showing results (21-30 of 43) with videos related to
Sort By:
Pageof 5
Global Public Health|November 15, 2016
The Trans Pacific Partnership Agreement and access to HIV treatment in VietnamHazel V J Moir, Brigitte Tenni, Deborah Gleeson, et al.Australian Health Review : a Publication of the Australian Hospital Association|November 9, 2017
Financial costs associated with monopolies on biologic medicines in AustraliaDeborah Gleeson, Belinda Townsend, Ruth Lopert, et al.Globalization and Health|October 26, 2018
Moderating the impact of patent linkage on access to medicines: lessons from variations in South Korea, Australia, Canada, and the United StatesKyung-Bok Son, Ruth Lopert, Deborah Gleeson, et al.Lancet (London, England)|June 28, 2002
Differential pricing of drugs: a role for cost-effectiveness analysis?Ruth Lopert, Danielle L Lang, Suzanne R Hill, et al.The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|January 8, 2013
Medication information for patients with limited English proficiency: lessons from the European UnionMarsha Regenstein, Ellie Andres, Dylan Nelson, et al.Health Affairs (Project Hope)|April 4, 2003
Comparing Medicare and private insurers: growth rates in spending over three decadesCristina Boccuti, Marilyn MoonHealth Services Research|March 19, 2011
Does medication adherence lower Medicare spending among beneficiaries with diabetes?Bruce Stuart, Amy Davidoff, Ruth Lopert, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 16, 2012
Simulated value-based insurance design applied to statin use by Medicare beneficiaries with diabetesAmy Davidoff, Ruth Lopert, Bruce Stuart, et al.The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|May 17, 2014
Transferability of results of cost utility analyses for biologicals in inflammatory conditions for Central and Eastern European countriesLászló Gulácsi, Fanni Rencz, Márta Péntek, et al.Pageof 5